Divis has been a compounding machine for the past 10 years. But the stock has corrected almost 50% from its all-time high.
In today’s thread, let us understand what are the reasons for this massive fall.

Like and retweet for maximum reach.
#Divis #DivisLabs #Pharma
This is the third time the stock has corrected by 50%, the last two times were during the 2008 financial crisis and in 2017 when they had received an import alert at their manufacturing facility. Divis went on to create massive wealth from there.
The first reason is the decline in sales for Molnupiravir. Molnupiravir is a Covid drug by Merck that can be administered orally. The company had given voluntary licenses to a lot of formulation companies that wanted to manufacture the drug.
Divi’s was the largest manufacturer of Molnupiravir API and benefited tremendously over the last year due to this. They were supplying the API not just to Merck, but also the formulation companies in India and other emerging countries.
Molnupiravir was a high margin drug for which they had done around ₹400 Cr of capex. So with the demand for Molnupiravir gone, they saw a reduction in the high margin business and some idle capacity which they are in the process of reorienting towards manufacturing other drugs.
These costs reduced their margins and the decline in Molnupiravir resulted in a decline in the higher margin CSM business and skewed the revenue mix towards their lower margin Generic API business. So the revenue mix became unfavorable for the company.
The lower margin Generic business faced its own set of problems. There was a lot of pricing pressure in their key molecules due to excess inventory in the channel. They also faced increased costs of key raw materials like lithium and iodine.
This resulted in further margin compression as they had a higher revenue contribution from the generic segment which faced a much higher margin compression due to a fall in prices and increase in costs.
Apart from these reasons, there is also a slowdown in the growth for the company. Divis has grown its topline at 20% CAGR for the past 10 years. But this year, they have faced a 9.7% decline in their top line.
The valuations for the company soared post the pandemic. The valuations were pricing in much higher growth rates and margins. The company has said that they are not expecting the growth and margins that they enjoyed during the pandemic to continue over the next few years.
This has resulted in a de-rating of the stock. (insert image 7)
Watch the detailed analysis:
Micro Cap Club:

• • •

Missing some Tweet in this thread? You can try to force a refresh

Keep Current with Value Educator

Value Educator Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!


Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @ValueEducator

Mar 26
Laurus Labs was all set to deliver a bumper year. But currently the stock is down 57% from its all-time high. Let us take a look at some of the reasons for this decline.

#laurus #lauruslabs #pharma

Like and retweet for maximum reach!! Image
The first reason is the reduction in their ARV business. While Laurus is trying to move away from their ARV business as it is a low margin business for the company, they are still very dependent on this segment.
The ARV segment (including API and FDF) contributed to 50% of their revenues in FY22 and about 35% in 9M FY23. Image
Read 21 tweets
Mar 24
#PeterLynch is a renowned American investor & mutual fund manager, during his tenure, he achieved an CAGR of 29.2% from 1977-1990

In this detailed thread let's understand about his investment strategies with which he has generated this CAGR!

Like & Retweet for better reach
There are 6 types of categories in which stocks can be placed:
Note: (Categories are just guidelines there are No hard and fast rules). He always tried to allocate all stocks in these 5 categories to make his research more manageable.
There are 6 Categories:
A- Slow Grower
B- Stalwarts
C- Fast Grower
D- Cyclical
E- Turnarounds

Let's understand about these categories in detail!
Read 24 tweets
Mar 23
We all start our investing journey with #WarrenBuffett - The greatest investor of all time

In this detailed thread I have covered some of the most interesting case studies and how he kept on improving his investment framework over the time !

Like and retweet for maximum reach! Image
Journey of Warren Buffet

Warren Buffet started his investing journey at the age of 13 by selling groceries from his grandfather’s shop. He sold chewing gum and newspapers door to door and simultaneously collected caps of Coca-Cola bottles. This was his first exposure to
Coca-Cola and from here he gradually built his understanding of Coca-Cola and created massive wealth by investing in this stock. He used a similar strategy to create massive wealth in his other investments as well.
Read 60 tweets
Mar 17
Detailed analysis on the business of Gravita India - A future giant in the recycling megatrend

CMP: ₹ 463

Like and Retweet for Better Reach!
Topics covered:

Company overview
Industry overview
Business verticals
Revenue Mix
Raw Materials
Value Chain
Manufacturing Plants
Company’s Key Focus Area
1) Company overview:
-Gravita India Ltd was established in 1990, with its first recycling plant at Jaipur, Rajasthan in 1994.The company is involved in the manufacturing of Lead through recycling Lead Acid batteries.The company has diversified into Aluminum and Plastic recycling,
Read 64 tweets
Mar 8
Detailed Analysis on the business of Tinna Rubber and Infrastructure - The largest integrated end-of-life Tyre Recycler in India.

CMP: ₹ 386

Like and Retweet for Maximum Reach!
Topics covered:
Company overview
Industry overview
Revenue Mix
Raw Materials
Value Chain
Manufacturing Plants
Company’s Key Focus Area
Previous Capex
Current Capex
Tinna Rubber & Infrastructure Limited (TRIL), was founded in 1977 by Mr. Bhupinder Kumar Sekhri.
Read 71 tweets
Mar 7
#PhilipFisher was an American stock investor and author who was best known for his scuttlebutt investment philosophy mentioned in his book "Common Stocks and Uncommon Profits in 1958”.This book also encouraged Warren Buffet to change his Investment style from Cigarbutt approach
to Investing in High quality business. He is widely regarded as one of the pioneers of modern investment theory, and his ideas and methods have had a significant impact on the world of investing.

Scuttlebutt was a term coined by Philip Fisher that refers to
the process of gathering information about a company through informal sources such as industry contacts, suppliers, customers, and employees. According to Fisher, scuttlebutt can provide valuable insights into a company's culture, management team, and competitive position that
Read 7 tweets

Did Thread Reader help you today?

Support us! We are indie developers!

This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!


0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy


3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us on Twitter!